TY - STD TI - Reducing and Preventing Adverse Drug Events To Decrease Hospital Costs [http://www.ahrq.gov/research/findings/factsheets/errors-safety/aderia/index.html] UR - http://www.ahrq.gov/research/findings/factsheets/errors-safety/aderia/index.html ID - ref1 ER - TY - JOUR AU - Singh, S. AU - Loke, Y. K. PY - 2012 DA - 2012// TI - Drug safety assessment in clinical trials: methodological challenges and opportunities JO - Trials VL - 13 UR - https://doi.org/10.1186/1745-6215-13-138 DO - 10.1186/1745-6215-13-138 ID - Singh2012 ER - TY - JOUR AU - Sakaeda, T. AU - Tamon, A. AU - Kadoyama, K. AU - Okuno, Y. PY - 2013 DA - 2013// TI - Data mining of the public version of the FDA adverse event reporting system JO - Int J Med Sci VL - 10 UR - https://doi.org/10.7150/ijms.6048 DO - 10.7150/ijms.6048 ID - Sakaeda2013 ER - TY - JOUR AU - Iyer, S. V. AU - Harpaz, R. AU - LePendu, P. AU - Bauer-Mehren, A. AU - Shah, N. H. PY - 2014 DA - 2014// TI - Mining clinical text for signals of adverse drug-drug interactions JO - J Am Med Inform Assoc VL - 21 UR - https://doi.org/10.1136/amiajnl-2013-001612 DO - 10.1136/amiajnl-2013-001612 ID - Iyer2014 ER - TY - JOUR AU - Avillach, P. AU - Dufour, J. C. AU - Diallo, G. AU - Salvo, F. AU - Joubert, M. AU - Thiessard, F. PY - 2013 DA - 2013// TI - Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project JO - J Am Med Inform Assoc VL - 20 UR - https://doi.org/10.1136/amiajnl-2012-001083 DO - 10.1136/amiajnl-2012-001083 ID - Avillach2013 ER - TY - JOUR AU - Schror, K. PY - 2007 DA - 2007// TI - Aspirin and Reye syndrome: a review of the evidence JO - Paediatr Drugs VL - 9 UR - https://doi.org/10.2165/00148581-200709030-00008 DO - 10.2165/00148581-200709030-00008 ID - Schror2007 ER - TY - JOUR AU - Guthrie, O. W. PY - 2008 DA - 2008// TI - Aminoglycoside induced ototoxicity JO - Toxicology VL - 249 UR - https://doi.org/10.1016/j.tox.2008.04.015 DO - 10.1016/j.tox.2008.04.015 ID - Guthrie2008 ER - TY - JOUR AU - Beltowski, J. AU - Wojcicka, G. AU - Jamroz-Wisniewska, A. PY - 2009 DA - 2009// TI - Adverse effects of statins - mechanisms and consequences JO - Curr Drug Saf VL - 4 UR - https://doi.org/10.2174/157488609789006949 DO - 10.2174/157488609789006949 ID - Beltowski2009 ER - TY - JOUR AU - Haber, P. AU - Sejvar, J. AU - Mikaeloff, Y. AU - DeStefano, F. PY - 2009 DA - 2009// TI - Vaccines and guillain-barre syndrome JO - Drug Saf VL - 32 UR - https://doi.org/10.2165/00002018-200932040-00005 DO - 10.2165/00002018-200932040-00005 ID - Haber2009 ER - TY - JOUR AU - Linkins, L. A. PY - 2013 DA - 2013// TI - Bleeding risks associated with vitamin K antagonists JO - Blood Rev VL - 27 UR - https://doi.org/10.1016/j.blre.2013.02.004 DO - 10.1016/j.blre.2013.02.004 ID - Linkins2013 ER - TY - JOUR AU - Stephenson, A. L. AU - Wu, W. AU - Cortes, D. AU - Rochon, P. A. PY - 2013 DA - 2013// TI - Tendon Injury and Fluoroquinolone Use: A Systematic Review JO - Drug Saf VL - 36 UR - https://doi.org/10.1007/s40264-013-0089-8 DO - 10.1007/s40264-013-0089-8 ID - Stephenson2013 ER - TY - STD TI - Medical Subjects Headings (MeSH) [http://www.nlm.nih.gov/mesh/] UR - http://www.nlm.nih.gov/mesh/ ID - ref12 ER - TY - STD TI - ATC/DDD Index [http://www.whocc.no/atc_ddd_index/] UR - http://www.whocc.no/atc_ddd_index/ ID - ref13 ER - TY - JOUR AU - Nelson, S. J. AU - Zeng, K. AU - Kilbourne, J. AU - Powell, T. AU - Moore, R. PY - 2011 DA - 2011// TI - Normalized names for clinical drugs: RxNorm at 6 years JO - J Am Med Inform Assoc VL - 18 UR - https://doi.org/10.1136/amiajnl-2011-000116 DO - 10.1136/amiajnl-2011-000116 ID - Nelson2011 ER - TY - STD TI - RxNorm API [http://rxnav.nlm.nih.gov/] UR - http://rxnav.nlm.nih.gov/ ID - ref15 ER - TY - JOUR AU - Kuhn, M. AU - Campillos, M. AU - Letunic, I. AU - Jensen, L. J. AU - Bork, P. PY - 2010 DA - 2010// TI - A side effect resource to capture phenotypic effects of drugs JO - Mol Syst Biol VL - 6 UR - https://doi.org/10.1038/msb.2009.98 DO - 10.1038/msb.2009.98 ID - Kuhn2010 ER - TY - JOUR AU - Jiang, G. AU - Liu, H. AU - Solbrig, H. R. AU - Chute, C. G. PY - 2013 DA - 2013// TI - ADEpedia 2.0: integration of normalized adverse drug events (ADEs) knowledge from the UMLS JO - AMIA Jt Summits Transl Sci Proc VL - 2013 ID - Jiang2013 ER - TY - JOUR AU - Cheng, F. AU - Li, W. AU - Wang, X. AU - Zhou, Y. AU - Wu, Z. AU - Shen, J. PY - 2013 DA - 2013// TI - Adverse drug events: database construction and in silico prediction JO - J Chem Inf Model VL - 53 UR - https://doi.org/10.1021/ci4000079 DO - 10.1021/ci4000079 ID - Cheng2013 ER - TY - JOUR AU - Siamouli, M. AU - Samara, M. AU - Fountoulakis, K. N. PY - 2014 DA - 2014// TI - Is antiepileptic-induced suicidality a data-based class effect or an exaggeration? A comment on the literature JO - Harv Rev Psychiatry VL - 22 UR - https://doi.org/10.1097/HRP.0000000000000039 DO - 10.1097/HRP.0000000000000039 ID - Siamouli2014 ER - TY - JOUR AU - Khouri, C. AU - Jean Bart, E. AU - Logerot, S. AU - Decker-Bellaton, A. AU - Bontemps, H. AU - Mallaret, M. PY - 2014 DA - 2014// TI - [Dysthyroidism with anti-VEGF treatment, a class effect? about One case report] JO - Therapie VL - 69 UR - https://doi.org/10.2515/therapie/2014063 DO - 10.2515/therapie/2014063 ID - Khouri2014 ER - TY - JOUR AU - Mir, O. AU - Coriat, R. AU - Gregory, T. AU - Ropert, S. AU - Billemont, B. AU - Goldwasser, F. PY - 2011 DA - 2011// TI - Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents JO - Invest New Drugs VL - 29 UR - https://doi.org/10.1007/s10637-010-9406-6 DO - 10.1007/s10637-010-9406-6 ID - Mir2011 ER - TY - JOUR AU - Standl, E. AU - Erbach, M. AU - Schnell, O. PY - 2014 DA - 2014// TI - Dipeptidyl-peptidase-4 inhibitors and heart failure: class effect, substance-specific effect, or chance effect? JO - Curr Treat Options Cardiovasc Med VL - 16 UR - https://doi.org/10.1007/s11936-014-0353-y DO - 10.1007/s11936-014-0353-y ID - Standl2014 ER - TY - JOUR AU - Saisho, Y. AU - Itoh, H. PY - 2013 DA - 2013// TI - Dipeptidyl peptidase-4 inhibitors and angioedema: a class effect? JO - Diabet Med VL - 30 UR - https://doi.org/10.1111/dme.12134 DO - 10.1111/dme.12134 ID - Saisho2013 ER - TY - JOUR AU - Dagan, Y. AU - Katz, G. PY - 2013 DA - 2013// TI - A case of atypical antipsychotic-induced somnambulism: a class effect JO - J Clin Psychiatry VL - 74 UR - https://doi.org/10.4088/JCP.12cr08283 DO - 10.4088/JCP.12cr08283 ID - Dagan2013 ER - TY - JOUR AU - Manen, R. P. AU - Fram, D. AU - DuMouchel, W. PY - 2007 DA - 2007// TI - Signal detection methodologies to support effective safety management JO - Expert Opin Drug Saf VL - 6 UR - https://doi.org/10.1517/14740338.6.4.451 DO - 10.1517/14740338.6.4.451 ID - Manen2007 ER - TY - JOUR AU - Schroeder, M. P. AU - Gonzalez-Perez, A. AU - Lopez-Bigas, N. PY - 2013 DA - 2013// TI - Visualizing multidimensional cancer genomics data JO - Genome Med VL - 5 UR - https://doi.org/10.1186/gm413 DO - 10.1186/gm413 ID - Schroeder2013 ER - TY - STD TI - DailyMed [http://dailymed.nlm.nih.gov/] UR - http://dailymed.nlm.nih.gov/ ID - ref27 ER - TY - JOUR AU - McAlister, F. A. AU - Laupacis, A. AU - Wells, G. A. AU - Sackett, D. L. PY - 1999 DA - 1999// TI - Users' guides to the medical literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect JO - JAMA VL - 282 UR - https://doi.org/10.1001/jama.282.14.1371 DO - 10.1001/jama.282.14.1371 ID - McAlister1999 ER - TY - JOUR AU - Harpaz, R. AU - DuMouchel, W. AU - LePendu, P. AU - Bauer-Mehren, A. AU - Ryan, P. AU - Shah, N. H. PY - 2013 DA - 2013// TI - Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system JO - Clin Pharmacol Ther VL - 93 UR - https://doi.org/10.1038/clpt.2013.24 DO - 10.1038/clpt.2013.24 ID - Harpaz2013 ER -